Bessemer Group Inc Pacira Bio Sciences, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 246 shares of PCRX stock, worth $4,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares

246

Previous 240 2.5%

Holding current value

$4,789

Previous $7,000 42.86%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$11.7 - $28.46 $70 - $170	6 Added 2.5%	246 $4,000
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $2,473 - $3,056	97 Added 67.83%	240 $7,000
Q1 2024 May 13, 2024	BUY	$27.7 - $35.48 $914 - $1,170	33 Added 30.0%	143 $4,000
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $2,147 - $2,806	70 Added 175.0%	110 $3,000
Q2 2023 Aug 10, 2023	BUY	$36.12 - $47.5 $1,444 - $1,900	40 New	40 $2,000
Q3 2022 Nov 09, 2022	BUY	$51.24 - $58.89 $3.05 Million - $3.51 Million	59,608 Added 90315.15%	59,674 $3.17 Million
Q1 2022 May 12, 2022	SELL	$60.03 - $76.49 $240 - $305	-4 Reduced 5.71%	66 $5,000
Q4 2021 Jan 27, 2022	BUY	$47.97 - $62.21 $3,357 - $4,354	70 New	70 $4,000
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $3,333 - $3,739	-61 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$59.18 - $69.99 $5,148 - $6,089	-87 Reduced 58.78%	61 $4,000
Q4 2020 Feb 09, 2021	BUY	$50.47 - $66.26 $7,469 - $9,806	148 New	148 $9,000
Q3 2020 Nov 12, 2020	SELL	$51.97 - $63.0 $660,019 - $800,100	-12,700 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$28.4 - $50.7 $360,680 - $643,890	12,700 New	12,700 $426,000
Q2 2019 Jul 19, 2019	SELL	$36.57 - $47.97 $877,680 - $1.15 Million	-24,000 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$36.47 - $42.17 $9,664 - $11,175	-265 Reduced 1.09%	24,000 $913,000
Q4 2018 Feb 12, 2019	BUY	$41.31 - $52.16 $991,440 - $1.25 Million	24,000 Added 9056.6%	24,265 $1.04 Million
Q3 2018 Nov 06, 2018	BUY	$32.85 - $52.0 $8,705 - $13,780	265 New	265 $13,000
Q4 2017 Jan 30, 2018	SELL	$31.85 - $46.95 $11,529 - $16,995	-362 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$35.7 - $39.5 $12,923 - $14,299	362	362 $14,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Pacira Bio Sciences, Inc. Transaction History